Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Small Cell Lung Carcinoma 9Carcinoma, Non-Small-Cell Lung 7Sarcoma 5Breast Neoplasms 4Triple Negative Breast Neoplasms 3Nasopharyngeal Carcinoma 3Thyroid Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Whole-Brain Radiotherapy 1Stomach Neoplasms 1Solid Tumors 1Small Cell Lung Cancer Extensive Stage 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Recurrence 1Proteinuria 1Progression Free Survival(PFS) 1Platinum-resistant Ovarian Cancer (PROC) 1Ovarian Neoplasms 1Lung Neoplasms 1Leiomyosarcoma 1HER2-Negative Breast Cancer 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Extensive Stage Lung Small Cell Cancer 1Esophageal Neoplasms 1

Interventions

Paclitaxel 15liposomal doxorubicin 8Carboplatin 8Bevacizumab 8pembrolizumab 7Topotecan 6olaparib 4mirvetuximab soravtansine 4Nivolumab 4Cyclophosphamide 4niraparib 3fludarabine 3Gemcitabine 3Drug Therapy 3rucaparib 2ribociclib 2pegfilgrastim 2palbociclib 2oregovomab 2fludarabine phosphate 2Irinotecan 2Hyperthermic Intraperitoneal Chemotherapy 2Fulvestrant 2Cisplatin 2Blood Specimen Collection 21-dodecylpyridoxal 2trastuzumab deruxtecan 1sacituzumab govitecan 1isoquercitrin 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × anlotinib × 1 year × Clear all
NCT07489300 2026-03-24

BACON

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Not yet recruiting
40 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡